Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Besifovir, a parent drug converted by LB80380, further metabolizes to its active form, LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 57.00 | |
2 mg | In stock | $ 83.00 | |
5 mg | In stock | $ 139.00 | |
10 mg | In stock | $ 217.00 | |
25 mg | In stock | $ 395.00 | |
50 mg | In stock | $ 588.00 | |
100 mg | In stock | $ 838.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 129.00 |
Description | Besifovir, a parent drug converted by LB80380, further metabolizes to its active form, LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV). |
In vivo | Besifovir (LB80380) is a relatively new oral acyclic nucleotide phosphonate. Areas covered: LB80380 is a prodrug of LB80331 and LB80317. It is rapidly absorbed when taken orally. Escalating doses of besifovir produce linear increase of the plasma concentration. Doses above 60mg are effective for inhibiting HBV in human. Using 60mg as an example, the maximal concentration of LB80331 in plasma is 397 ng/mL. |
Molecular Weight | 299.22 |
Formula | C10H14N5O4P |
CAS No. | 441785-25-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (835.51 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Besifovir 441785-25-7 Microbiology/Virology HBV LB80331 LB 80331 Inhibitor LB-80331 Hepatitis B virus inhibit inhibitor